Table. Recommended vaccines for people before and after a solid organ transplant

• Recipients <10 years of age and not previously vaccinated should receive at least 3 primary doses as DTPa-containing vaccine, and then follow the routine schedule for their age.
• Recipients ≥10 years of age and not previously vaccinated should receive the 1st dose as dTpa, followed by 2 doses of dT. If dT is unavailable, complete vaccination course with dTpa.
• Adults who have received at least 3 primary doses of a diphtheria-tetanus-pertussis–containing vaccine should receive a dose of dTpa after transplant if their last dose was more than 10 years ago.
• See also Catch-up vaccination. 

• If possible, complete vaccination before transplantation.

Recommended for:

• all liver solid organ transplant recipients
• transplant candidates or recipients with chronic liver disease
• those chronically infected with either hepatitis B or hepatitis C

• Recommended for all seronegative solid organ transplant candidates. Immunogenicity is likely to be improved when candidates receive the vaccine before transplantation.
• Can use an accelerated schedule before transplantation— see Table. Accelerated hepatitis B vaccination schedules for people with imminent risk of exposure.

• 1 dose is recommended for people who are immunocompetent and start vaccination before their 26th birthday.
• 3-dose schedule (0, 2, 6 months) is recommended for people who are immunocompetent and start vaccination after their 26th birthday.
• If a person has a solid organ transplant before completing the course, a 3-dose schedule is recommended.
• 3-dose schedule (0,  2,  6 months) of 9vHPV is recommended for people who are vaccinated after transplant.
• For people >25 years of age, conduct a risk assessment to determine their need for vaccination.
• For more details, see Human papillomavirus.

• Adults who have received a routine course of polio vaccination in childhood are recommended to receive a booster every 10 years if they plan to travel to a polio-endemic area or have an occupational risk of polio exposure (eg laboratory workers).

• 2  doses in 1st  year after transplant should be given 4 weeks apart.
• Children aged 6  months to <9 years are recommended to receive 2 doses before transplant if they are receiving influenza vaccine for the 1st  time.

• MenB vaccine is recommended for certain age groups and individuals with specific risk factors placing them at increased risk of invasive meningococcal disease (see Meningococcal disease).
• The number of doses varies with age. See Table. Recommendations for MenB vaccine for people with a specified medical condition that increases their risk of invasive meningococcal disease in Meningococcal disease.

• MenACWY is recommended for certain age groups and individuals with specific risk factors placing them at increased risk of invasive meningococcal disease (see Meningococcal disease).
• The number of doses varies with age. See Table. Recommendations for MenACWY vaccine for people with a specified medical condition that increases their risk of invasive meningococcal disease in Meningococcal disease.

• Confirm immunity by serological testing before transplantation.
• If seronegative, complete a 2-dose primary vaccination schedule for children and adults before transplantation, provided the person is not immunocompromised at that time.

• 1 dose (in addition to those routinely offered in childhood). See Pneumococcal disease and Table. Catch-up schedule for pneumococcal conjugate vaccines for Aboriginal and Torres Strait Islander children living in NT, Qld, SA or WA ONLY, and all children with risk condition(s) for pneumococcal disease, aged <5 years.

• 2 doses at least 5 years apart. See Pneumococcal disease and Table. Catch-up schedule for pneumococcal conjugate vaccines for Aboriginal and Torres Strait Islander children living in NT, Qld, SA or WA ONLY, and all children with risk condition(s) for pneumococcal disease, aged <5 years.

• Confirm immunity by serological testing before transplantation.
• If seronegative, complete a 2-dose primary vaccination schedule for children and adults before transplantation, provided the person is not immunocompromised at that time.

• Shingrix is registered for people aged ≥18 years who are immunocompromised.
• Vaccination post-transplant and cessation of anti-viral prophylaxis is preferred.
• 2 doses 2-6 months apart prior to transplantation.
• 2 doses 1-2 months apart following transplantation.